XML 15 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Jun. 30, 2020
Dec. 31, 2019
Current assets:    
Cash and cash equivalents $ 4,085 $ 3,335
Accounts receivable, net of allowances of $120 in 2020 and $112 in 2019 1,884 1,896
Inventories 1,905 1,653
Prepaid expenses and other current assets 692 619
Total current assets 8,566 7,503
Property, plant and equipment, net 4,382 4,512
Goodwill 3,052 3,030
Other intangible assets, net 1,716 1,471
Operating lease right-of-use assets 581 608
Other non-current assets 1,168 1,069
Total assets 19,465 18,193
Current liabilities:    
Short-term debt 1 226
Current maturities of long-term debt and finance lease obligations 318 315
Accounts payable and accrued liabilities 2,561 2,689
Total current liabilities 2,880 3,230
Long-term debt and finance lease obligations 6,055 4,809
Operating lease liabilities 488 510
Other non-current liabilities 1,882 1,732
Total liabilities 11,305 10,281
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2020 and 2019 683 683
Common stock in treasury, at cost, 173,312,541 shares in 2020 and 177,340,358 shares in 2019 (10,597) (10,764)
Additional contributed capital 5,975 5,955
Retained earnings 16,055 15,718
Accumulated other comprehensive (loss) income (3,988) (3,710)
Total Baxter stockholders’ equity 8,128 7,882
Noncontrolling interests 32 30
Total equity 8,160 7,912
Total liabilities and equity $ 19,465 $ 18,193